The neuroethics of non-invasive brain stimulation  by Kadosh, Roi Cohen et al.
Current Biology Vol 22 No 4
R108Essay
The neuroethics of non-invasive brain stimulation
Transcranial direct current stimulation (TDCS) is a brain stimulation tool that 
is portable, painless, inexpensive, apparently safe, and with potential long-
term efficacy. Recent results obtained from TDCS experiments offer exciting 
possibilities for the enhancement and treatment of normal or impaired abilities, 
respectively. We discuss new neuroethical problems that have emerged from 
the usage of TDCS, and also focus on one of the most likely future applications 
of TDCS: enhancing learning and cognition in children with typical and atypical 
development.Roi Cohen Kadosh1,2, Neil Levy3,4,5, 
Jacinta O’Shea2,6, Nicholas Shea3,4,7, 
and Julian Savulescu3,4,8
There is perennial interest in the 
neuroscience community in using 
its expanding understanding of the 
brain to devise ways of enhancing 
brain functions and, consequently, 
human abilities [1]. The main aim is 
usually to improve the abilities — and 
therefore the lives — of people with 
cognitive and other psychological 
disabilities. Most existing efforts to 
improve these abilities have focused 
on pharmacological interventions. In 
recent years, however, we have seen 
a new wave of research exploring 
whether non-invasive brain stimulation 
(NIBS) might be beneficial. NIBS 
methods, such as transcranial 
electrical stimulation (TES) and 
transcranial magnetic stimulation 
(TMS), especially in combination 
with behavioural training, offer 
promising alternatives or adjuvant 
strategies for conditions in which 
pharmacological intervention has not 
been successful [2]. In this Essay, 
we focus on transcranial direct 
current stimulation (TDCS), the most 
frequently used mode of TES. This 
recently emerging and easily applied 
technique raises the main neuroethical 
dilemmas of NIBS techniques and 
makes some issues particularly 
pressing. 
In TDCS, weak electrical currents, 
for example 1 mA, are applied for a 
short duration (~20 minutes) to the 
head via electrodes that are placed on 
the scalp. The currents pass through 
the skull and alter spontaneous 
neural activity. Studies in animals 
and humans have found that anodal 
stimulation pushes neural resting 
membrane potentials closer to the 
activation threshold and therefore 
increases tissue excitability, while cathodal stimulation inhibits cell firing 
and decreases excitability [3]. 
The long-lasting effects of TDCS, 
which can persist for up to 12 
months [4], are protein synthesis-
dependent and are accompanied by 
modifications of intracellular cAMP 
and calcium levels [5], and therefore 
share some features with long-term 
potentiation and long-term depression 
[6]. Experiments in humans have 
found that following TDCS there are 
changes in the local concentration 
of the neurotransmitters GABA and 
glutamate, important in synaptic 
mechanisms implementing learning 
and memory [6].
These characteristics of TDCS 
make it an attractive tool for 
manipulating neurobehavioural 
plasticity and underlie its potential as 
an adjuvant intervention for cognitive 
rehabilitation. Compared with other 
NIBS techniques, TDCS is portable, 
painless, inexpensive, apparently safe,
and therefore feasible for home use. 
Most importantly, growing evidence 
indicates that TDCS has the key 
distinct advantage of enhancing 
psychological functions with potential 
long-term efficacy [5,7].
TDCS studies have shown that it 
is possible to enhance fundamental 
human capacities, such as motor 
and sensorimotor skills, vision, 
decision making and problem 
solving, mathematical cognition, 
language, memory, and attention — 
improvements that seem to persist 
without apparent cognitive side 
effects [2]. We shall refer to all these 
different skills, from basic sensory 
abilities to higher cognitive functions, 
as ‘psychological’ functions.
New ethical issues
TDCS has the potential not only to 
treat congenital or acquired neural 
disease or dysfunction but also to  
enhance the psychological skills of 
subjects already performing within 
the normal range [5,7]. The issue of 
cognitive enhancement using TDCS 
raises special ethical issues that differ 
in important ways from those raised 
by pharmacological interventions 
[8]. First, once a TDCS machine has 
been purchased, it can be used at 
any time, even many years later, for 
any function, by anyone. Although 
Food and Drug Administration (FDA) 
approval is required for marketing 
purposes, the FDA cannot prevent 
its wider use. 
Second, the relative cheapness and 
portability of TDCS means its use is 
not restricted to laboratories or clinics. 
Indeed, some companies already offer 
the device for personal use at home 
by adults. 
Third, unlike pharmaceuticals, 
TDCS is not ingested into the body. 
People may intuit a moral difference 
between external enhancements, 
such as education or computing, and 
internal enhancements, such as drugs. 
While external enhancements, such 
as education, can be dangerous, for 
example when they are used to breed 
hate, and internal enhancements, 
such as nutrition, can be used for 
better health and cognition, there 
seems to be a widespread perception 
that external enhancements are 
less problematic than internal 
ones. The intuition that TDCS is an 
external intervention may create the 
misplaced perception that its use is 
less problematic than more obviously 
internal enhancements, and thus lower 
the threshold for premature use [9]. 
Last, TDCS can be applied to any 
cortical brain area, including areas 
beyond that for which its use may 
be indicated. Moreover, it can have 
enduring effects [5,7]. 
These unique features of TDCS 
technology raise important ethical 
issues for scientists, ethicists, policy 
makers and the general public. 
Other ethical issues are similar to 
those pertaining to other medical 
interventions [10]. It is the potential 
application of TDCS for improving 
psychological functioning in children 
(Figure 1) that causes most concern, 
as we will discuss in the next section.
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Figure 1. Ethics of using non-invasive brain stimulation in children.
The usage of non-invasive brain stimulation in children to improve psychological functions raises 
many important scientific and ethical questions, such as: Which is the appropriate brain area to 
be stimulated? What is the effect of brain stimulation on the developing brain? Is there a possibil-
ity that cognitive enhancement of some abilities occurs at a cost to others? Might there be cur-
rently unknown safety issues and potential hazards at the psychological level and physiological 
level? The current picture is for demonstration purposes only. We discuss what necessary steps 
are needed in order to allow typically and atypically developing children to benefit from the usage 
of non-invasive brain stimulation. Stimulating the developing brain 
Premature use of TDCS
The fact that the technology is so 
simple and easy to apply raises 
distinctive issues. The apparatus is 
relatively inexpensive (some forms 
of TES machines can be purchased 
for less than £500), can be built 
using off-the-shelf components (for 
example http://www.electronicspoint.
com/9-volt-battery-stepped-down-1-
2-milliamps-t10189.html) and, when 
used within suggested guidelines, 
the acute safety risks (of seizures, for 
example) seem very low (in contrast 
to TMS, there are no reports of 
seizures) [11]. As a result there is a 
danger that it can be tried out ad hoc 
on adults and children — especially 
on vulnerable patient groups seeking 
help with serious and currently 
intractable developmental disorders 
(such as autism, epilepsy, dyscalculia, 
dyslexia or schizophrenia) — before 
enough is known about potential 
psychological side effects, about the 
appropriate method of stimulating (for 
example, the optimal duration and 
location of stimulation) and about how
psychological training protocols can 
be designed that are selective for the 
desired effects.
As little is yet known about the 
best ways to utilize TDCS, there 
is no training program or licensing 
regime for clinicians applying the 
technique. Inadequately trained 
clinicians might misidentify suitable 
sites for stimulation — an important 
issue as different cognitive abilities 
may be subserved by different brain 
areas at different stages across the 
life span [12]. They might also fail to 
ensure that stimulation parameters 
are within safety guidelines (indeed, 
such guidelines have not yet been 
devised for the developing brain). 
And they might combine NIBS with 
inappropriate behavioural training. 
At best, this situation could result in 
the exploitation of vulnerable patients 
or parents for financial gain; at 
worst, it may risk long-term damage 
to the brain and exacerbate the 
disadvantage, potentially worsening 
other psychological functions. 
For example, repeated stimulation 
of the parietal cortex in order to 
increase numerical competence 
during developmental stages 
when the prefrontal cortex is more 
important [13] might not only fail to 
give any improvement but it could 
even worsen performance and lead to atypical brain development. Like 
other types of atypical experience 
during sensitive periods [14], the 
stimulation of the wrong brain area 
might induce abnormal patterns 
of brain activity in this brain region 
and interconnected areas, and 
increase metabolic consumption 
in brain areas that are irrelevant to 
the specific psychological function. 
Hence, research into the safety and 
potential hazards of TDCS in children 
is urgently needed. This will enable 
parents and clinicians to be better 
informed of the risks involved in 
applying the technique and for the 
appropriate training of people who 
will administer TDCS for different 
conditions in different age groups.
Should we stimulate the developing 
brain? 
Some issues pertaining to the 
application of NIBS to children 
are relatively familiar from other 
contexts [15], such as the need to 
obtain valid consent either from a 
competent adolescent or from the 
primary caretaker, usually a parent. 
An issue that is more specific to the 
use of TDCS, as well as other NIBS 
techniques, in children concerns its possible effects on brain development 
and the degree to which enhancing 
some capacities may lead to a 
deterioration of other capacities. To 
date, most research on cognitive 
enhancement using pharmacological 
agents or NIBS has focused on 
improving average or impaired 
abilities. However, such enhancement 
may come at a cost in some cases 
[16]. Highly-developed capacities in 
certain cognitive domains in some 
individuals are accompanied by 
reduced functioning in others [17]. 
It would be premature to allow 
children, or their parents, to make 
the choices that lead to higher 
functioning in one domain (such as 
language) at a cost to functioning 
in other valuable domains (such 
as face recognition), as they might 
lack understanding of the ways in 
which the development of cognitive 
abilities may depend on earlier 
cognitive functions, as well as on 
brain organisation [12]. We recognize 
that parents have a great deal of 
leeway over what they might do to 
their children; for example, we allow 
them to do things that cannot be 
expected to better their children 
(such as feed them largely on crisps). 
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negative effects of an enhancement 
are, it might be appropriate to block 
parents’ access to the enhancement. 
We do already consider it grounds for 
intervention if parents do things that 
are too detrimental to their children, 
for example, if they refuse to educate 
them. In addition, there are things 
that parents may legitimately do to 
their children, but which medical 
or scientific authorities should not 
enable or facilitate. Therefore, those 
involved in the professional use 
of TDCS should not facilitate the 
choices of parents if the side effects 
are sufficiently bad, or sufficiently ill 
understood.
If TDCS does enhance some 
abilities at a cost to others, then 
assessing its ethical permissibility 
will involve weighing its costs and 
benefits. By contrast, if treatments 
like TDCS are shown to be clearly 
in a child’s best interest, without 
detrimental effects on other 
psychological functions, parents 
should have no ethical (or legal, at 
least in Anglo-American jurisdictions) 
right to refuse them for their children. 
This could mean that TDCS might 
in the future become mandatory 
as a treatment for developmental 
disorders. Indeed, if TDCS were 
shown to significantly improve 
acquisition of core skills in normal 
children, it might become as 
mandatory as basic education.
It is not possible to assess the 
safety of TDCS for higher cognitive 
functions such as language, reading, 
or mathematics via standard pre-
clinical experimental routes (for 
example, using animal models). As 
the mature brain and the developing 
brain differ in anatomy and function 
[12], data on the effect of TDCS on 
the mature brain may not reveal 
possible side effects of stimulating 
a developing brain. Further, the 
atypically developing brain may 
respond differently from the typically 
developing brain. Thus, it seems 
impossible to gather adequate data 
on efficacy and side effects without 
testing the specific target population 
directly. In addition, it is still unclear 
whether adverse effects might occur 
in younger subjects that do not seem 
to appear in adults (for example, 
seizures or cognitive impairments).
Some might argue that in light of 
this lack of understanding, scientists 
should not proceed to examine the potential use of TDCS in children. The 
issues that we raise in this section 
are indeed difficult to address. 
However, we believe that failing to 
address them would deprive a large 
population of children of potentially 
improved psychological abilities, 
which would have adverse individual 
and social implications [18]. For 
example, enhancing the mathematical 
skills of children opens up wider 
employment opportunities for them 
and benefits society in general [18].
NIBS, behavioural training and 
cheating
Much of neurorehabilitation and 
therapy requires patients to re-
learn old or acquire new ways of 
implementing behaviours because the 
normal neural pathways have been 
compromised by injury. Evidence 
from healthy controls suggests 
that NIBS can boost psychological 
functions [5,7]. Combining NIBS with 
an appropriate training regime may 
boost the gain of the rehabilitation 
intervention, yielding larger and 
long-lasting functional improvements. 
With this approach, the behavioural 
training is the key driver of change, 
but NIBS may play an important role 
in ‘priming’ the neural environment, 
making the brain more receptive to 
the training effects.
An intriguing and open question 
that is of clear scientific, clinical and 
ethical interest is whether NIBS-
induced changes would be specific 
to the trained tasks only, or whether 
the beneficial effects might generalize 
to other kinds of performance. 
Generalization of skill learning is 
usually desirable, but needs to be 
balanced against the concern that 
NIBS-enhanced performance on 
one cognitive measure may entail 
decrements on other measures [16].
The current consensus is that TDCS 
is likely to prove most effective when 
coupled with appropriate behavioural 
training. If this is true, it reduces 
a common objection to cognitive 
enhancements: the objection that 
artificially induced capacities do not 
belong authentically to the person. 
We think that the widespread view 
that individuals can make aspects of 
their personality authentically their 
own by taking responsibility for them 
through protracted use is extremely 
plausible. This consideration 
would also reduce the force of 
the objection that enhancement constitutes cheating — gives the 
person an unearned and therefore 
unfair advantage — to the extent 
to which that worry rests on the 
thought that the enhanced ability 
comes to the person without 
requiring an investment of effort. 
It might also suggest that one of 
the most effective — and ethically 
controversial — ways of achieving 
effective enhancement is by 
intervening during early development 
and affecting learning and the 
acquisition and consolidation of 
cognitive abilities. In this respect, 
the attribution to TDCS of the label 
that it is a ‘thinking cap’ [10] might 
be erroneous as it does not cause 
thinking per se, but depends primarily 
on the learning process. 
Conclusions and future directions
NIBS, and more specifically TDCS, 
could prove to be an important means 
of treating psychiatric disorders, 
neurological conditions, and currently 
intractable disorders of psychological 
development. It could also improve 
psychological processes in the healthy 
population, and thus offer benefits at 
the individual and societal level [18]. 
But there is a substantial risk that it 
could be utilized prematurely, before 
proper protocols are established, 
and potentially before unwanted side 
effects are well understood, especially 
with regards to children.
To overcome these obstacles, 
we suggest starting by translating 
established research findings from 
adults (which have shown TDCS to be 
safe and effective) to children. Both 
atypically and typically developing 
children may be justifiable subjects, 
although it could be that only one 
type of population might benefit from 
the usage of NIBS. However, the 
following safeguards are important: 
First, data about psychological 
side effects should be collected, 
including medium-term (say, three 
to six months) and long-term (say, 
one year) follow-ups after the initial 
intervention, using a variety of tests 
to assess potential long-term effects 
on the psychological processes 
of interest, as well as on other 
psychological functions. Because of 
time constraints, it is only possible 
to examine children on a limited 
number of tests. We suggest that the 
particular tests should be decided 
based on the involvement of the 
stimulated brain area and nearby 
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functions. However, it is possible 
that psychological functions that are 
subserved by remote brain areas 
would be affected as a result of 
reallocation of blood flow and energy 
substrates (such as oxygen) to the 
stimulated brain area. Therefore, at 
the first stage a variety of tests should 
be used, and if there is no trend for 
psychological side effects, these tests 
should be replaced with other tests 
on the same type of population. 
Second, experiments in children 
should start with small samples to 
avoid exposing a large population 
to potential risks. Once the desired 
effect of TDCS has been established, 
the experiments should be scaled up 
to larger randomized double-blinded 
controlled trials. 
Third, the population should be 
recruited from different social-
economic classes and ethnic groups, 
and barriers which would inhibit the 
recruitment of a wide spectrum of 
children should be eliminated. 
Fourth, the developing brain 
should be monitored for possible 
neurochemical, anatomical, 
and functional changes that are 
associated with TDCS. This can be 
achieved by using non-invasive and 
safe neuroimaging methods, such as 
magnetic resonance spectroscopy, 
diffusion tensor imaging, functional 
MRI, electroencephalography or near 
infrared spectroscopy. Assessment 
should focus not only on the 
intended induced neural alterations 
in the stimulated brain area, but 
also monitor for possible changes in 
remote brain areas that mediate other 
psychological functions.
Another issue is whether the 
effects shown by NIBS are clinically 
significant. What is the ecological 
validity of findings in a lab to everyday 
life? As with every new technology, 
most of the results so far are from 
controlled experiments in a lab 
setting. Therefore, the current results 
are based mainly on improvements 
at the level of milliseconds or 
percentage accuracy. However, some 
findings have shown that TDCS is 
able to improve performance not only 
quantitatively but also qualitatively 
by inducing a profile of behaviour 
that matches a more advanced 
developmental stage [2]. Others have 
shown that TDCS can be used to 
improve naming ability in patients with 
chronic aphasia [19]. The future use of NIBS, and its possible application 
in clinical settings or educational 
systems, should provide further 
evidence as to whether the current 
findings with NIBS have a real-world 
value as a therapy or enhancement in 
settings outside the lab.
There are also other pending 
questions that need to be addressed 
in the future, such as: who should 
be funding this type of research, 
particularly if it might become 
obligatory for parents? Is it too risky 
for parents to permit their children to 
participate in NIBS experiments given 
the current state of knowledge? If yes, 
how is such participation different 
from other strenuous and risky things 
parents are allowed to do (such as 
crossing the road at a red light with 
their child or allowing a child at the 
beginning of primary school to have a 
mobile phone)? If there are unforeseen 
adverse side effects, how should we 
attribute responsibility and blame?
In sum, ethical obstacles can and 
should be overcome. If it is handled 
judiciously, TDCS could prove to be 
an inexpensive and widely-deployed 
technology with substantial benefits 
to individuals and society.
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